Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Site Staff / Welcome from the GRC Chair
7:40 pm - 9:30 pm
Keynote Session: Disease Mechanisms and Phenotypes
Discussion Leader: Leslie Thompson (University of California, Irvine, USA)
7:40 pm - 8:20 pm
Henry Paulson (University of Michigan Health System, USA)
"CAG Repeat Diseases: Genotype-Phenotype Correlations"
8:20 pm - 8:30 pm
Discussion
8:30 pm - 9:10 pm
Judith Frydman (Stanford University, USA)
"Protein Quality Control and Protein Misfolding in Disease"
9:10 pm - 9:20 pm
Discussion
9:20 pm - 9:30 pm
General Discussion
Monday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Common Pathogenic Mechanisms in Neurodegenerative Diseases
Discussion Leaders: Diane Merry (Thomas Jefferson University, USA) and Harry Orr (University of Minnesota, USA)
9:00 am - 9:25 am
Jeffrey Rothstein (Johns Hopkins University, USA)
"Dysfunction of Nuclear Pore Complex in Huntington's Disease and ALS"
9:25 am - 9:35 am
Discussion
9:35 am - 10:00 am
Robert Richards (University of Adelaide, Australia)
"Autoinflammatory Disease as a Common Mechanism for Late-Onset Neurodegeneration"
10:00 am - 10:10 am
Discussion
10:10 am - 10:40 am
Coffee Break
10:40 am - 10:55 am
Selected from Poster Abstracts: Christopher Pearson (The Hospital for Sick Children, Canada)
"Parent-of-Origin Effect for Congenital Myotonic Dystrophy"
10:55 am - 11:05 am
Discussion
11:05 am - 11:20 am
Selected from Poster Abstracts: Anna Pluciennik (Thomas Jefferson University, USA)
"Role of USP7 in the Pathogenicity of Spinal and Bulbar Muscular Atrophy"
11:20 am - 11:30 am
Discussion
11:30 am - 11:45 am
Selected from Poster Abstracts: Joern Huelsmeier (Trinity College Dublin, Ireland)
"Endogenous Ataxin2 CAG Repeats and Intrinsically Disordered Domains Are Necessary for RNA-Granule Formation and Olfactory Long-Term Memory"
11:45 am - 11:55 am
Discussion
11:55 am - 12:10 pm
Selected from Poster Abstracts: Edward Wild (University College London, United Kingdom)
"Neurofilament Light Protein in Blood as a Biomarker for Neurodegeneration in Huntington's Disease"
12:10 pm - 12:20 pm
Discussion
12:20 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
The Toxic Conformer: Does It Exist?
Discussion Leaders: Laura Ranum (University of Florida College of Medicine, USA) and Christopher Ross (Johns Hopkins University, USA)
7:30 pm - 7:55 pm
Ronald Melki (CNRS, France)
"Propagation of α-Synuclein and HTT Aggregates"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 8:20 pm
Meewhi Kim (University of Texas Southwestern Medical Center, USA)
"Conformations of N-Terminal HTT Fragments: Structural Investigations"
8:20 pm - 8:25 pm
Discussion
8:25 pm - 8:50 pm
Matthew Disney (The Scripps Research Institute, USA)
"RNA Structures as Mediators of Disease"
8:50 pm - 8:55 pm
Discussion
8:55 pm - 9:15 pm
Louise Serpell (University of Sussex, United Kingdom)
"Amyloid Structures and Mechanisms of Toxicity"
9:15 pm - 9:20 pm
Discussion
9:20 pm - 9:30 pm
General Discussion
Tuesday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
Impairment of DNA Repair and RNA Mechanisms in CAG Repeat Diseases
Discussion Leaders: Kimberly Kegel-Gleason (Massachusetts General Hospital, USA) and Matthew Disney (The Scripps Research Institute, USA)
9:00 am - 9:20 am
Lesley Jones (MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, United Kingdom)
"DNA Repair in the Trinucleotide Repeat Disorders"
9:20 am - 9:30 am
Discussion
9:30 am - 9:50 am
Hitoshi Okazawa (Tokyo Medical and Dental University, Japan)
"Impaired DNA Damage Repair in SCA1 and Other CAG Repeat Diseases"
9:50 am - 10:00 am
Discussion
10:00 am - 10:15 am
Selected from Poster Abstracts: Jacob Loupe (Massachusetts General Hospital, USA)
"Functional Prioritization of Huntington's Disease Onset Modifiers in the Mouse"
10:15 am - 10:20 am
Discussion
10:20 am - 10:50 am
Coffee Break
10:50 am - 11:10 am
Partha Sarkar (University of Texas Medical Branch, USA)
"DNA Damage-Response Pathways in SCA3 and Huntington's Disease"
11:10 am - 11:20 am
Discussion
11:20 am - 11:35 am
Selected from Poster Abstracts: Vincent Dion (University of Lausanne, Switzerland)
"Contracting CAG/CTG Repeat Using the CRISPR-Cas9 Nickase"
11:35 am - 11:40 am
Discussion
11:40 am - 11:55 am
Selected from Poster Abstracts: Shyam Ramachandran (Children's Hospital of Philadelphia, USA)
"Mutant Huntingtin Disrupts CELF1-MBNL1 Regulation in Patient Brain and Model Systems"
11:55 am - 12:00 pm
Discussion
12:00 pm - 12:15 pm
Selected from Poster Abstracts: Carlo Rinaldi (University of Oxford, United Kingdom)
"More than One Protein: Role of Androgen Receptor Isoforms in SBMA Pathogenesis"
12:15 pm - 12:20 pm
Discussion
12:20 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
What Can We Learn from Large OMIC Data Sets for Disease Research?
Discussion Leaders: Gillian Bates (University College London, United Kingdom) and James Rosinski (CHDI Foundation, USA)
7:30 pm - 7:50 pm
William Yang (David Geffen School of Medicine at UCLA, USA)
"Analysis of RNAseq and Proteomics Data in Models of HD"
7:50 pm - 7:55 pm
Discussion
7:55 pm - 8:15 pm
Smita Saxena (University of Bern, Switzerland)
"The Synaptic Protein Homer-3 Influences SCA1 Pathophysiology"
8:15 pm - 8:20 pm
Discussion
8:20 pm - 8:40 pm
Harry Orr (University of Minnesota, USA)
"Spinocerebellar Ataxia Type 1: Molecular Basis of Neurodegeneration in the Cerebellum (Ataxia) and Brainstem (Lethality)"
8:40 pm - 8:45 pm
Discussion
8:45 pm - 9:00 pm
Selected from Poster Abstracts: Christian Neri (Pierre-and-Marie-Curie University, France)
"Weighted Network Models of the Temporal Dynamics and Biological Outcome of Huntington's Disease"
9:00 pm - 9:05 pm
Discussion
9:05 pm - 9:20 pm
Selected from Poster Abstracts: Andrea Reyes-Ortiz (University of California, Irvine, USA)
"Transcriptomic and Functional Analysis of HD iPSC-Derived Brain Microvascular Endothelial Cells Reveals Angiogenic and BBB Deficits"
9:20 pm - 9:25 pm
Discussion
9:25 pm - 9:30 pm
General Discussion
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Proteostasis and Protein Quality Control Mechanisms in Disease
Discussion Leaders: Eric Reits (University of Amsterdam, The Netherlands) and Joan Steffan (University of California, Irvine, USA)
9:00 am - 9:25 am
Nico Dantuma (Karolinska Institutet, Sweden)
"Polyglutamine Proteins and the Ubiquitin/Proteasome System"
9:25 am - 9:35 am
Discussion
9:35 am - 10:00 am
Janine Kirstein (Leibniz Institute for Molecular Pharmacology, Germany)
"Complete Suppression of HTT Fibrilization and Disaggregation of HTT Fibrils by a Trimeric Chaperone Complex"
10:00 am - 10:10 am
Discussion
10:10 am - 10:25 am
Selected from Poster Abstracts: Mark Hipp (Max Planck Institute of Biochemistry, Germany)
"Architecture of PolyQ Inclusions"
10:25 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
Harm Kampinga (University Medical Center Groningen, The Netherlands)
"HSPs as Potential Therapy Targets in Neurodegeneration"
11:25 am - 11:30 am
Discussion
11:30 am - 11:55 am
Ai Yamamoto (Columbia University, USA)
"Clearance of PolyQ Proteins in Mammalian Cells"
11:55 am - 12:00 pm
Discussion
12:00 pm - 12:15 pm
Selected from Poster Abstracts: Rocio Gomez Pastor (Duke University School of Medicine, USA)
"Heat Shock Transcription Factor 1: A Neuroprotective Role in Huntington's Disease"
12:15 pm - 12:20 pm
Discussion
12:20 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
From Molecules to Humans: Selected Poster Presentations / Selected GRS Presentations
Discussion Leaders: Åsa Petersén (Lund University, Sweden) and Sarah Tabrizi (University College London, United Kingdom)
7:30 pm - 7:50 pm
Beverly Davidson (The Children's Hospital of Philadelphia, USA)
"Development of Innovative Therapeutic Strategies for CAG Repeat Diseases"
7:50 pm - 8:00 pm
Discussion
8:00 pm - 8:15 pm
Selected from Poster Abstracts: Nicolas Arbez (Johns Hopkins School of Medicine, USA)
"Modulation of Huntingtin Toxicity by Post-Translational Modifications"
8:15 pm - 8:20 pm
Discussion
8:20 pm - 8:35 pm
Selected from Poster Abstracts: Anastasia Gromova (University of California, San Diego, USA)
"Elucidating Mechanisms of Skeletal Muscle-Driven Neurodegeneration in Spinal and Bulbar Muscular Atrophy"
8:35 pm - 8:40 pm
Discussion
8:40 pm - 8:55 pm
Selected from Poster Abstracts: Anne Steinhof (Max Delbrueck Center for Molecular Medicine in the Helmholtz Association, Germany)
"Mutant HTT Seeding Activity: A Marker of Disease Progression in Models of Huntington's Disease"
8:55 pm - 9:00 pm
Discussion
9:00 pm - 9:15 pm
Radhia Kacher (CNRS / Pierre and Marie Curie University, France)
"zQ175 Knock-In Mouse Model Helps to Decipher the Neuroprotective Role of CYP46A1, the Cholesterol Degradation Enzyme, in Huntington's Disease"
9:15 pm - 9:20 pm
Discussion
9:20 pm - 9:30 pm
General Discussion
Thursday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Business Meeting
Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair
9:00 am - 12:30 pm
Innovative Technologies, Model Systems and Quantitative Methods
Discussion Leaders: Blair Leavitt (University of British Columbia, Canada) and Erich Wanker (Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Germany)
9:00 am - 9:25 am
Andreas Weiss (Evotec AG, Germany)
"Quantitative CNS Disease Protein Assays for Screening and Biomarker Applications"
9:25 am - 9:35 am
Discussion
9:35 am - 10:00 am
Elena Cattaneo (University of Milan, Italy)
"Organoid Models for CAG Repeat Diseases"
10:00 am - 10:10 am
Discussion
10:10 am - 10:25 am
Selected from Poster Abstracts: Xiao-Jiang Li (Emory University, USA)
"CRIPSR/Cas9-Mediated Therapeutic Effect in HD Knock-In Mice"
10:25 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
Fanny Mochel (Pierre and Marie Curie University, France)
"Metabolic Imaging and Metabolomics in Polyglutamine Diseases"
11:25 am - 11:30 am
Discussion
11:30 am - 11:55 am
Beatriz Alvarez-Castelao (Max Planck Institute for Brain Research, Germany)
"Identification of Newly Synthesized Proteomes in the Brain"
11:55 am - 12:00 pm
Discussion
12:00 pm - 12:15 pm
Selected from Poster Abstracts: Danielle Simmons (Stanford University, USA)
"TSPO-PET Imaging Using 18 F-PBR06 Is a Potential Biomarker for Monitoring Therapeutic Efficacy in Huntington's Disease: Preclinical Evidence with the Small Molecule p75NTR Ligand LM11A-31"
12:15 pm - 12:20 pm
Discussion
12:20 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Innovative Therapeutic Strategies and Diagnostic Tools
Discussion Leaders: Edward Wild (University College London, United Kingdom) and Henry Paulson (University of Michigan Health System, USA)
7:30 pm - 7:50 pm
Sarah Tabrizi (University College London, United Kingdom)
"Meeting the Therapeutic Challenge of HD"
7:50 pm - 7:55 pm
Discussion
7:55 pm - 8:15 pm
Albert La Spada (University of California, San Diego, USA)
"Novel Therapeutic Strategies for PolyQ Diseases"
8:15 pm - 8:20 pm
Discussion
8:20 pm - 8:40 pm
Gulin Oz (University of Minnesota, USA)
"Treatment Monitoring by Magnetic Resonance Spectroscopy in Neurodegenerative Diseases"
8:40 pm - 8:45 pm
Discussion
8:45 pm - 9:00 pm
Selected from Poster Abstracts: Hayley McLoughlin (University of Michigan, USA)
"Toward Antisense Oligonucleotide Therapy for Spinocerebellar Ataxia Type 3"
9:00 pm - 9:05 pm
Discussion
9:05 pm - 9:20 pm
Selected from Poster Abstracts: Matt Scaglione (Medical College of Wisconsin, USA)
"CHIPping Away at Polyglutamine"
9:20 pm - 9:25 pm
Discussion
9:25 pm - 9:30 pm
General Discussion
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure